Skip to main content

Military Health System

Top Military Medical Doctor Predicts Coronavirus Longevity

Image of Army Lt. Gen. Ronald J. Place, director of Defense Health Agency, delivers remarks at a media briefing on COVID-19 at the Pentagon, April 21, 2021. Army Lt. Gen. Ronald J. Place, director of Defense Health Agency, delivers remarks at a media briefing on COVID-19 at the Pentagon, April 21, 2021. (DOD photo by Lisa Ferdinando)

Recommended Content:

Coronavirus & the MHS Response | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

COVID-19 and other such coronaviruses likely will stay in the environment and continue to mutate, Army Lt. Gen. Ronald J. Place, director of Defense Health Agency, said.

"And we're going to have to deal with it," he told participants today at the Sea-Air-Space Exposition at National Harbor, Maryland, on the topic of the COVID-19 response and post-pandemic national security.

The United States is in an "OK place, but not a great place," at this point in the COVID-19 pandemic, he said, adding, "I think one of the things that many of us believe — which is a fallacy — is that [COVID-19] is going to go away. It's not going away, just like influenza is not going away. And the thing about many viruses is they tend to mutate, and they tend to do things that keep them alive."

One of the things people should feel comfortable with is the Defense Department medical team has insatiable curiosity, he told the audience, adding that medical research is a continuous process of improvement.

Place said the first order of illness always calls for prevention, followed by diagnosis.

"We're interested in taking care of everybody — service members, family members, retirees — but the Military Health System exists for the military," the general said. "That's our purpose. And so we think about service members and what we can do to keep them healthy.  … What piece of gear, what piece of anything can we use to prevent anything bad from happening to them?" It can be something infectious such as a cold, or an emerging injury, he noted.

Looking at COVID-19 from a military scientific perspective, it is a biological event, he said. And the COVID-19 vaccine should be considered biological body armor.

However, the general said, "Tens of thousands of Americans die every year from influenza, and while most of us in the uniformed services get vaccinated, most Americans actually don't. That's a problem for us."

The reason the United States has such a suite of good vaccines "isn't because that magical thinking happened by some manufacturers in the spring of 2020," Place said. "This is [research] based on years, in some cases, and more than a decade of research on how to take the vaccination methodology to a new level."

There are huge improvements in the way we're looking at how vaccines work, he said. "And I believe we will get to a place where we're not talking about COVID all the time." He warned, however, that getting that peace of mind probably won't happen this year.

"We will get to a place where it's going to be another infectious disease that we worry about, or we think about — much like influenza, measles or tetanus" where people get vaccinations to ward off diseases, Place said. "It's going to be part of our reality for a long time."

You also may be interested in...

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

DHA-IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.

Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

Establishes the DHA's procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits for enduring COVID-19 support.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

Supplemental Guidance for Providing DOD Coronavirus Disease 2019 Vaccines to DOD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

Showing results 1 - 12 Page 1 of 1
Refine your search
Last Updated: September 01, 2021
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery